Tatsuta Takeo

Affiliation and department：
Job title：助教

Research field (1)： Pharmaceuticals - health and biochemistry

Research theme for competitive and other funds (3)：

Papers (33)：

Takeo Tatsuta, Jun Ito, Koji Yamamoto, Shigeki Sugawara, Masahiro Hosono, Makoto Sato, Taeko Miyagi. Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer. Biomedicines. 2024. 12. 1
Jun Ito, Shigeki Sugawara, Takeo Tatsuta, Masahiro Hosono, Makoto Sato. Catfish Egg Lectin Enhances the Cytotoxicity of Sunitinib on Gb3-Expressing Renal Cancer Cells. Biomedicines. 2023. 11. 8
Leonardo Marques da Fonseca, Takeo Tatsuta, Seung-Yeol Park, Leonardo Freire-de-Lima. Editorial: Drug-resistance in cancer cells: A new wine in an old bottle. Frontiers in oncology. 2023. 13. 1161008-1161008
Takeo Tatsuta, Masahiro Hosono. Discovery of antitumor effects of leczymes. Glycoconjugate Journal. 2022. 39. 2. 157-165
Takeo Tatsuta. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2022. 142. 10. 1045-1053

ｍore...

MISC (9)：

伊藤淳, 菅原栄紀, 岩村大径, 阿南剛, 海法康裕, 立田岳生, 細野雅祐, 佐藤信. ナマズ卵レクチンは腎癌細胞においてSunitinibの効果を増強する. 日本泌尿器科学会総会. 2018. 106回. PP2-013
佐藤稔之, 立田岳生, 菅原栄紀, 原明義, 細野雅祐. シアル酸結合性レクチン(cSBL)のEGFR pathwayへの影響. 日本薬学会年会要旨集. 2018. 138年会. 3. 58-58
佐藤稔之, 立田岳生, 菅原栄紀, 原明義, 細野雅祐. 悪性中皮腫細胞に対する抗腫瘍性リボヌクレアーゼとペメトレキセド、シスプラチンの抗腫瘍効果の比較・併用研究. 日本薬学会年会要旨集. 2017. 137年会. 3. 93-93
Hosono Masahiro, Tatsuta Takeo. Current status and foresight of antitumor ribonucleases. Journal of Tohoku Pharmaceutical University. 2014. 61. 11-25
HOSONO Masahiro, SUGAWARA Shigeki, TATSUTA Takeo, NITTA Kazuo. Structure,Function and Carbohydrate Recognition of Fish Lectins:A Possible Application for Burkitt's Lymphoma. Journal of Tohoku Pharmaceutical University. 2013. 60. 35-47

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page